Benitec Biopharma Reports Continued Durable Improvements In The Radiographic Assessments Of Swallowing Efficiency And The Subject-Reported Outcome Instrument At The 180-Day Timepoint

HAYWARD: Benitec Biopharma Inc., a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary 'Silence and Replace' DNA-directed RNA interference platform, today announces continued durable improvements [...]